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Abstract
Objective—Develop clinically applicable charts of lipid values illustrating fluctuations
throughout childhood and by sex among healthy weight children.
Methods—The National Health and Nutrition Examination Survey (1999–2008) was used to
estimate total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and
triglycerides by age and sex in healthy weight children age 3 to 17 years. Using LMS procedures,
the authors created smoothed curves demonstrating population-based 50th percentile for age and
the 75th and 95th percentiles.
Results—The curves were based on 7681 children meeting inclusion criteria. Total cholesterol,
HDL, and LDL demonstrated peaks at approximately 8 to 12 years for boys. Similar peaks were
evident for girls at slightly younger ages, approximately 7 to 11 years. Triglycerides showed peaks
for girls, but values were similar across ages for boys.
Conclusions—The use of fixed lipid value cutoffs in established guidelines regardless of age or
sex likely mislabels many children as abnormal. The authors’ charts may allow for a more
nuanced interpretation based on population norms.
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Introduction
Serum lipid values vary by age through childhood and are also affected by sex, race, and
other factors.1–4 Recently, Cook et al1 published population-based lipid distributions with
curves throughout childhood, which reinforced that there are variations in lipid values,
particularly around ages 8 to 14. By tracking serum cholesterol values through childhood
and graphing them, the charts clearly demonstrate that a static cutoff of normal and
abnormal, as currently recommended,2 is inappropriate based on the dynamic physiology of
children at different ages. Currently, the American Academy of Pediatrics recommends
screening for lipid abnormalities in all overweight children from after age 2 years to no later
than 10 years of age and that those with abnormal values should be treated for
hypercholesterolemia, initially with lifestyle changes, followed by statin treatment for those
over age 8, should lifestyle changes fail.2 These current definitions of normal are based on
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single cutoff values for children, regardless of age and gender. Thus, the use of sex-stratified
“cholesterol curves” based on a population of healthy weight children and adolescents could
enhance the interpretation of isolated total cholesterol (TC) or subcomponent values and
help guide clinical decision-making.
Unfortunately, because of the known relationship between excess weight and
hyperlipidemia, curves that include the full population of children including the obese, as
previous reports have,1,5 cannot necessarily be inferred as healthy standards or “normal” and
therefore have limited applicability to clinical decision making. Since obesity is known to
affect lipid values and obesity rates have increased over the years, population-based
cholesterol curves may be inappropriately increased relative to what “normal” or “healthy”
TC levels should be through the physiologic changes of childhood. Because of this and the
fact that screening usually depends on comparison to a healthy population, curves that
demonstrate lipid values in a healthy population could provide useful clinical information to
aid in interpretation of cholesterol screening results. Therefore, we sought to develop
clinically relevant lipid distribution charts by including only healthy weight children and
excluding those with lipid values potentially indicative of familial hypercholesterolemia,
which could provide a better understanding of healthy children’s distributions of lipid
values.
Methods
This study is based on the repeated cross sections of the National Health and Nutrition
Examination Survey (NHANES) from 1999 to 2008. NHANES is a stratified, multistage
probability sample of the civilian, non-institutionalized population of the United States. It
includes computer-based interviews, an in-home questionnaire on a variety of demographic
and health topics, an examination including a thorough physical exam with measured
heights and weights, and laboratory measures.6
Fasting
Previous work, including work using a population identical to ours, demonstrates very
minimal differences in lipid values in children based on fasting time.7 Adequate sample size
is critical to the creation of population distribution curves, and limiting only fasting values
left far too few children for reliable estimates, particularly for low-density lipoprotein (LDL)
and triglycerides among young children. Therefore, we chose to include all children,
regardless of fasting status, in our analyses. Examinations of curves limited to children who
had fasted for at least 8 hours showed few differences in the patterns across age, but with
greater instability in the estimates.
Sample
We included children ages 3 to 17 years, who had at least 1 of the 4 common lipid
measurements available (TC, high-density lipoprotein [HDL], LDL, or triglycerides). We
used height and weight as measured during the examination component to calculate body
mass index (BMI) and determine percentile, using SAS code developed for that purpose.8
Using standard definitions, we included only children who were of healthy weight (BMI 5th
to 85th percentile for age and sex). We excluded children with very high values that could
indicate familial hyperlipidemia (10 with cholesterol greater than 300 mg/dL, 4 with LDL
greater than 200 mg/dL, and 3 with triglycerides greater than 350 mg/dL).
Laboratory Methods
Equipment for lipid analyses varied through the years. In 1999–2004, a Roche Hitachi 704
Analyzer was used, and a Roche Hitachi 717 was used in 2005. A Roche Hitachi 912 was
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used in 2006, and a Roche Modular P in 2007–2008. No adjustments were needed for the
changes in equipment.9,10
TC was measured enzymatically in serum or plasma for all years of data collection. HDL
cholesterol in 1999–2002 was measured using a heparin-manganese precipitation, or direct
measurement for children ages 3 to 5, because of small sample volumes. Beginning in 2003,
all samples were tested using a direct immunoassay. Although changes in HDL values
across time indicate possible laboratory method differences, our focus on age-based
differences averaged over the period did not necessitate further adjustments. Triglycerides
were measured enzymatically in serum for all years. LDL was calculated from total
cholesterol, HDL, and triglycerides as follows: [LDL-cholesterol] = [total cholesterol] −
[HDL-cholesterol] − [triglycerides/5].
Statistical Methods
We used Cole’s LMS procedures to create population-based curves of lipid values
throughout childhood,11,12 which is similar but not identical to those used to create the CDC
growth charts.13 Although sample sizes of 100 at each age point have been recommended
for growth curves, smaller sample sizes can be sufficient.14 See Table 1 for the sample sizes
at each age for each of the lipid measures. Sample sizes are small, particular among 3- to 5-
year-old children. This suggests that some caution should be used when interpreting data at
these young ages; however, we present data for all age groups. The exception is that we
exclude 3-year-old children from our triglyceride analyses because of extreme standard
errors in the values at this age.
As opposed to a prepackaged program, we used Stata 11.0 (College Station, TX) to calculate
the L, M, and S parameters as described by Cole.11,12 All analyses were adjusted for the
complex survey design of NHANES and were performed using the survey estimation
routines in Stata. This study was deemed exempt from institutional review board review
under federal regulation 45 CFR §46.101(b) because it used only de-identified secondary
data.
Results
The curves (see Figures 1–4) were based on 7681 children who met inclusion criteria. TC,
HDL, and LDL demonstrated peaks at ~8 to 12 years for boys. Similar peaks were evident
for girls, though at slightly younger ages, ~7 to 11 years. Triglycerides showed peaks for
girls, but values were similar across ages for boys.
The curves demonstrate important differences from currently recommended cutoff values.
Children around age 9 to 10 at the 95th percentile have total cholesterol values ~15 mg/dL
higher than younger children or adolescents. Although the 95th percentile is similar to or
lower than the static cutoff of 200 mg/dL for younger children and adolescents, it is clearly
higher for children in middle childhood.
Discussion
Our findings confirm previous findings of differences in lipids throughout childhood.1,4 We
extend these findings by using a nationally representative sample of healthy weight children
and excluding those with extremely elevated lipid values suggesting familial hyperlipidemia
syndromes, to create curves that will help clinicians interpret lipid screening results.
Current established guidelines for lipid screening and treatment use fixed lipid value cutoffs
regardless of age or sex and are based on population norms that include children who are
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obese and may have familial hyperlipidemia. This likely mislabels many children as
“abnormal” and leads to overtreatment of some children with lipid lowering medications as
there are clear lipid variations based on age and sex.
The preadolescent peaks in HDL and LDL values for both girls and boys and for triglyceride
values for girls could represent physiologic changes that cause lipid variations, and thus
examining a patient’s lipid values against these curves could be helpful in guiding lipid
management. The differences in appearances between the boys’ and girls’ percentile values
are a good reminder of sex-based differences. While there has been some adult literature
examining cholesterol differences by sex15 as well as variation during the menstrual cycle
for women,16 the pediatric differences may be even more stark.
There are several important limitations of this study. First, we use only cross-sectional data,
so we are unable to demonstrate if individual children follow the patterns we show.
However, we use a method comparable to those used to create the clinical growth charts,
which also rely on cross-sectional data. Second, we were unable to look at variations by
race/ethnicity. Sample size limited our ability to examine additional subpopulations in
addition to sex. Although race is related to lipid values, patterns of lipid values may be
similar throughout childhood.
Future research is needed to examine whether individual children follow these cholesterol
curves over time and to determine appropriate abnormal cut-points for lipid values based on
age, sex, and race/ethnicity. Additionally, there is a need to have increased sample size in
very young children so we can obtain a better understanding about the distribution of lipid
values in this group. Some previous studies have demonstrated that children with abnormal
values in childhood often have normal values in adulthood17 or even just 3 years later.18
One possible explanation for this is the natural variations seen in the population norms we
present in this study. It is not known whether these natural variations are detrimental to
cardiovascular health, and future studies are needed to elucidate this relationship as well.
Conclusions
Although we do not delineate for a particular percentile to be defined as abnormal in this
study, the ability for providers to clearly see how a child’s lipid values compare to other
children without known risk factors provides useful additional clinical information that can
assist in the care of children after lipid screening. Thus, these charts may allow for a more
nuanced interpretation based on population norms for healthy weight children.
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Distribution of total cholesterol by age
Solid line indicates recommended static cutoff value.
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Distribution of HDL cholesterol by age
Solid line indicates recommended static cutoff value.
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Distribution of LDL cholesterol by age
Solid line indicates recommended static cutoff value.
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Distribution of triglycerides by age
Static cut off value is 150 mg/dL.
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